Holdings
38
Concentrated
Top 10 weight
60%
Concentration
Active share
-
Style
Equity
96%
Asset allocation
Portfolio
-Sectors
6High-conviction bets
-Top sector wt.
0.0%Cash
Market-cap allocation
Large cap36%
Mid cap21%
Small cap39%
Asset allocation
Equity96%
Top holdings
12.2%
8.2%
Mankind Pharma Ltd.EQUITY
7.0%Cipla Ltd.EQUITY
6.7%Alkem Laboratories Ltd.EQUITY
5.7%Divi's Laboratories Ltd.EQUITY
5.6%4.3%
TREPSCASH_EQUIVALENT
3.8%3.7%
3.1%
2.9%
Biocon Ltd.EQUITY
2.6%2.6%
Abbott India Ltd.EQUITY
2.5%Lupin Ltd.EQUITY
2.3%2.2%
2.1%
Pfizer Ltd.EQUITY
1.9%1.7%
1.6%
1.5%
Blue Jet Healthcare Ltd.EQUITY
1.5%1.4%
1.4%
Hikal Ltd.EQUITY
1.3%1.3%
1.3%
Aurobindo Pharma Ltd.EQUITY
1.2%1.1%
Aarti Drugs Ltd.EQUITY
1.1%0.8%
FDC Ltd.EQUITY
0.8%Windlas Biotech Ltd.EQUITY
0.8%Laxmi Dental Ltd.EQUITY
0.8%Indoco Remedies Ltd.EQUITY
0.6%0.4%
Net Current AssetsCASH_EQUIVALENT
0.2%Cash Margin - DerivativesCASH_EQUIVALENT
0.0%AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- High top-10 concentration (60%).
- Small-cap heavy (39%) - higher volatility.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
75.8%
11.5%
5.3%
1.3%
1.3%
0.8%